Cassava Sciences Inc(SAVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SAVA Cassava Sciences Inc

未开盘 07-19 16:00:00 EDT

10.08

-0.10

-0.98%

盘后10.27

+0.19+1.89%

19:59 EDT

最高10.68	最低9.98	成交量237.18万
今开10.26	昨收10.18	日振幅6.88%
总市值4.84亿	流通市值4.53亿	总股本4,798万
成交额2,445万	换手率5.27%	流通股本4,498万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SAVA","market":"US","secType":"STK","nameCN":"Cassava Sciences Inc","latestPrice":10.08,"timestamp":1721419200000,"preClose":10.18,"halted":0,"volume":2371779,"hourTrading":{"tag":"盘后","latestPrice":10.2708,"preClose":10.08,"latestTime":"19:59 EDT","volume":25679,"amount":260872.0072,"timestamp":1721433557956},"delay":0,"floatShares":44983110,"shares":47976166,"eps":-2.1719,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.1,"latestTime":"07-19 16:00:00 EDT","open":10.26,"high":10.68,"low":9.98,"amount":24449543.115975,"amplitude":0.068762,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.1719,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721635200000},"adr":0,"adjPreClose":10.18,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":10.27,"preClose":10.18,"latestTime":"09:29 EDT","volume":8153,"amount":83509.05106700001,"timestamp":1721395790217},"postHourTrading":{"tag":"盘后","latestPrice":10.2708,"preClose":10.08,"latestTime":"19:59 EDT","volume":25679,"amount":260872.0072,"timestamp":1721433557956},"volumeRatio":0.4347336213032149,"impliedVol":1.8556,"impliedVolPercentile":0.9881},"requestUrl":"/m/hq/s/SAVA","defaultTab":"news","newsList":[{"id":"2452871944","title":"木薯科学盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452871944","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452871944?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:04","pubTimestamp":1721311491,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时04分，木薯科学股票出现波动，股价急速拉升5.02%。截至发稿，该股报10.05美元/股，成交量105.677万股，换手率2.20%，振幅6.03%。木薯科学股票所在的生物技术行业中，整体涨幅为0.03%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182204519681e172&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182204519681e172&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4585","BK4007","SAVA","BK4588"],"gpt_icon":0},{"id":"2452540511","title":"木薯科学盘中异动 股价大跌26.02%报10.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452540511","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452540511?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:31","pubTimestamp":1721223112,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时31分，木薯科学股票出现波动，股价快速下跌26.02%。截至发稿，该股报10.01美元/股，成交量296.24万股，换手率6.17%，振幅5.32%。木薯科学股票所在的生物技术行业中，整体跌幅为0.74%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071721315295cedd0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071721315295cedd0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","SAVA","BK4007","BK4547"],"gpt_icon":1},{"id":"2452159330","title":"盘前暴跌逾30%！Cassava CEO离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2452159330","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452159330?lang=zh_cn&edition=full","pubTime":"2024-07-17 20:50","pubTimestamp":1721220605,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Cassava Sciences周三宣布了管理层变动，Richard Barry接任公司首席执行官兼董事会执行主席。消息传出后，Cassava周三美股盘前暴跌逾30%。此外，Cassava神经科学高级副总裁Lindsay Burns也将离开公司。Barry自2021年6月以来一直担任Cassava的董事。自2015年6月以来，他还担任生物技术公司Sarepta Therapeutics的董事;2019年6月至2020年10月，他担任生物制药公司MiMedx Group的董事。另外，Cassava表示，正在审查其披露做法，以确保向利益相关者提供清晰全面的信息。","market":"us","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1152296.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"管理层大变动！Cassava CEO离职","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","BK4585","SAVA","BK4547","BK4588"],"gpt_icon":1},{"id":"2452151196","title":"盘前暴跌逾30%！Cassava(SAVA.US)CEO离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2452151196","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452151196?lang=zh_cn&edition=full","pubTime":"2024-07-17 20:40","pubTimestamp":1721220000,"startTime":"0","endTime":"0","summary":"Cassava Sciences周三宣布了管理层变动，Richard Barry接任公司首席执行官兼董事会执行主席。消息传出后，Cassava周三美股盘前暴跌逾30%。随着新CEO的任命，董事会计划将董事长和CEO的角色分开。此外，Cassava神经科学高级副总裁Lindsay Burns也将离开公司。Barry自2021年6月以来一直担任Cassava的董事。自2015年6月以来，他还担任生物技术公司Sarepta Therapeutics的董事;2019年6月至2020年10月，他担任生物制药公司MiMedx Group的董事。另外，Cassava表示，正在审查其披露做法，以确保向利益相关者提供清晰全面的信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/hkstocknews/2024-07-17/doc-incemyqs0237242.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkstocknews/2024-07-17/doc-incemyqs0237242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK4547","BK4007","BK4585","SAVA"],"gpt_icon":0},{"id":"2452153098","title":"生物技术公司 Cassava Sciences 首席执行官卸任","url":"https://stock-news.laohu8.com/highlight/detail?id=2452153098","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452153098?lang=zh_cn&edition=full","pubTime":"2024-07-17 20:10","pubTimestamp":1721218215,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透7月17日 - Cassava Sciences   周三表示，首席执行官Remi Barbier已经辞职，该生物技术公司任命Richard Barry为临时首席执行官。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAVA"],"gpt_icon":0},{"id":"2452910151","title":"木薯科学盘中异动 大幅拉升5.43%报13.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452910151","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452910151?lang=zh_cn&edition=full","pubTime":"2024-07-17 00:38","pubTimestamp":1721147904,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日00时38分，木薯科学股票出现波动，股价急速拉升5.43%。截至发稿，该股报13.00美元/股，成交量96.594万股，换手率2.01%，振幅7.62%。木薯科学股票所在的生物技术行业中，整体涨幅为0.11%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717003824af929c6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717003824af929c6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4547","SAVA","BK4007"],"gpt_icon":0},{"id":"2451625653","title":"木薯科学盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451625653","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451625653?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:06","pubTimestamp":1721052376,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日22时06分，木薯科学股票出现异动，股价快速上涨5.01%。截至发稿，该股报12.09美元/股，成交量29.0398万股，换手率0.61%，振幅3.65%。木薯科学股票所在的生物技术行业中，整体涨幅为0.42%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715220617af926602&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715220617af926602&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4585","BK4588","SAVA","BK4007"],"gpt_icon":0},{"id":"2450813802","title":"木薯科学盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450813802","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450813802?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:39","pubTimestamp":1720618780,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时39分，木薯科学股票出现波动，股价大幅拉升5.19%。截至发稿，该股报12.15美元/股，成交量21.9008万股，换手率0.46%，振幅7.71%。木薯科学股票所在的生物技术行业中，整体涨幅为0.07%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213941941f5d40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213941941f5d40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","BK4547","BK4007","SAVA","LGVN","VRPX","BK4585"],"gpt_icon":0},{"id":"2450236080","title":"木薯科学盘中异动 急速上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450236080","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450236080?lang=zh_cn&edition=full","pubTime":"2024-07-09 21:51","pubTimestamp":1720533064,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日21时51分，木薯科学股票出现波动，股价快速拉升5.18%。截至发稿，该股报10.35美元/股，成交量29.9275万股，换手率0.62%，振幅5.59%。木薯科学股票所在的生物技术行业中，整体跌幅为0.57%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709215104aef8baed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709215104aef8baed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","SAVA","BK4585","BK4547","BK4007"],"gpt_icon":0},{"id":"2449702624","title":"木薯科学盘中异动 大幅下跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449702624","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449702624?lang=zh_cn&edition=full","pubTime":"2024-07-08 23:20","pubTimestamp":1720452019,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日23时20分，木薯科学股票出现波动，股价急速下挫5.53%。截至发稿，该股报9.65美元/股，成交量108.843万股，换手率2.27%，振幅8.22%。木薯科学股票所在的生物技术行业中，整体涨幅为0.80%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082320229681ab05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082320229681ab05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","BK4547","VRPX","SAVA","BK4588"],"gpt_icon":0},{"id":"2449216659","title":"木薯科学盘中异动 下午盘急速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449216659","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449216659?lang=zh_cn&edition=full","pubTime":"2024-07-06 02:50","pubTimestamp":1720205431,"startTime":"0","endTime":"0","summary":"北京时间2024年07月06日02时50分，木薯科学股票出现波动，股价急速跳水5.01%。截至发稿，该股报10.23美元/股，成交量191.552万股，换手率3.99%，振幅7.80%。木薯科学股票所在的生物技术行业中，整体涨幅为0.98%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706025032941f47d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706025032941f47d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4588","BK4585","BK4547","SAVA"],"gpt_icon":0},{"id":"2449075204","title":"港股异动 | 绿叶制药(02186)现涨近3% 米美欣(羟考酮纳洛酮缓释片)在中国获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2449075204","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449075204?lang=zh_cn&edition=full","pubTime":"2024-07-05 09:34","pubTimestamp":1720143268,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，绿叶制药(02186)现涨近3%，截至发稿，涨2.84%，报2.9港元，成交额392.59万港元。消息面上，绿叶制药公告，集团镇痛领域新产品－米美欣(羟考酮纳洛酮缓释片，LY021702)已于2024年6月28日获得中国国家药品监督管理局的上市批准，适用于成人需阿片类镇痛药才能充分控制的重度疼痛(癌痛和非癌痛)。据悉，米美欣是当前唯一一款在国内获批上市、具有高技术壁垒的国产羟考酮纳洛酮缓释片。公司相信，米美欣解决了当前的临床需求，在中国具备良好的市场潜力。同时，该产品可与集团的抗肿瘤产品形成丰富的产品组合，并协同肿瘤领域现有的资源与优势，加速推动公司在该领域布局和发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1145958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","HSCEI","07226","BK4585","BK4007","02186","YANG","BK4588","BK1191","SAVA","BK1606","BK4547","HSTECH"],"gpt_icon":0},{"id":"2448449493","title":"绿叶制药(02186)：米美欣®(羟考酮纳洛酮缓释片)在中国获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2448449493","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448449493?lang=zh_cn&edition=full","pubTime":"2024-07-04 19:03","pubTimestamp":1720091010,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿叶制药 发布公告，集团镇痛领域新产品-米美欣已于2024年6月28日获得中华人民共和国国家药品监督管理局的上市批准，适用于成人需阿片类镇痛药才能充分控制的重度疼痛。米美欣是当前唯一一款在国内获批上市、具有高技术壁垒的国产羟考酮纳洛酮缓释片。除了用于癌痛管理之外，羟考酮纳洛酮缓释片还在多项临床试验中证实能为肌肉骨胳疼痛、术后疼痛、腰痛等中重度疼痛患者提供有效镇痛治疗，并可显著改善患者的便秘。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1145785.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK4547","02186","BK1606","BK4588","BK4585","BK1583","BK4007","SAVA"],"gpt_icon":0},{"id":"2448484836","title":"木薯科学盘中异动 快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448484836","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448484836?lang=zh_cn&edition=full","pubTime":"2024-07-03 23:11","pubTimestamp":1720019465,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日23时11分，木薯科学股票出现波动，股价大幅下跌5.00%。木薯科学股票所在的生物技术行业中，整体跌幅为1.88%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。根据TipRanks数据显示，该分析师近一年总胜率为25.9%，总平均回报率为6.9%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703231105af90689f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703231105af90689f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAVA"],"gpt_icon":0},{"id":"2448913125","title":"木薯科学股价重挫14.41% 市值跌7307.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448913125","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448913125?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:31","pubTimestamp":1719840667,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时31分，木薯科学股票出现波动，股价急速跳水14.41%。截至发稿，该股报10.57美元/股，成交量214.059万股，换手率4.46%，振幅1.05%。木薯科学股票所在的生物技术行业中，整体跌幅为0.05%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。根据TipRanks数据显示，该分析师近一年总胜率为25.9%，总平均回报率为6.9%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213107955f500d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213107955f500d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAVA"],"gpt_icon":0},{"id":"2448308918","title":"BUZZ-木薯科学公司在美国监管机构调查后成立小组，股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2448308918","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448308918?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:25","pubTimestamp":1719840311,"startTime":"0","endTime":"0","summary":"    7月1日 - ** Cassava Sciences   股价盘前下跌16.8%，至10.28美元 ** 在美国监管机构的调查下，生物技术公司称其董事会正在组建  一个委员会，负责指导对公司两名高级雇员的调查工作** 该公司称，已与美国司法部和美国证券交易委员会就对两名员工的调查进行了接触** 联邦检察官周五在  起诉医学教授王浩彦，指控他提交虚假数据，代表自己和一家未具名公司获得数百万美元的公共资金，用于一种治疗老年痴呆症药物的研究。** 截至收盘，股价年累计下跌 45.1%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4585","SAVA","BK4547","BK4588","BUZZ"],"gpt_icon":0},{"id":"2448990471","title":"更新版 1-木薯科学公司在美国监管机构调查两名员工后成立内部小组","url":"https://stock-news.laohu8.com/highlight/detail?id=2448990471","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448990471?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:16","pubTimestamp":1719839817,"startTime":"0","endTime":"0","summary":"此前，联邦检察官在上周五表示，曾与卡萨瓦公司合作的医生王浩岩代表自己和一家未具名公司，在向美国国立卫生研究院提交的拨款申请中编造了数据 。2021 年，两名与卡萨瓦公司无关的医生声称，卡萨瓦公司名为西姆非拉姆的阿尔茨海默氏症药物的基础研究是基于被篡改和歪曲的数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","BK4585","BK4007","SAVA","BK4588"],"gpt_icon":0},{"id":"2443671947","title":"木薯科学盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443671947","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443671947?lang=zh_cn&edition=full","pubTime":"2024-06-14 23:05","pubTimestamp":1718377508,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日23时05分，木薯科学股票出现异动，股价快速拉升5.08%。截至发稿，该股报20.90美元/股，成交量21.958万股，换手率0.46%，振幅6.37%。木薯科学股票所在的生物技术行业中，整体跌幅为0.24%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061423050896814582&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061423050896814582&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","SAVA","BK4547","BK4588"],"gpt_icon":0},{"id":"2435519295","title":"木薯科学盘中异动 早盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435519295","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435519295?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:32","pubTimestamp":1715693526,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时32分，木薯科学股票出现异动，股价大幅拉升5.26%。截至发稿，该股报21.71美元/股，成交量4.8581万股，换手率0.10%，振幅0.73%。木薯科学股票所在的生物技术行业中，整体涨幅为0.14%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421320687e87cbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421320687e87cbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","SAVA","BK4588","BK4585","BK4007"],"gpt_icon":0},{"id":"2435379566","title":"木薯科学盘中异动 股价大涨5.19%报21.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435379566","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435379566?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:09","pubTimestamp":1715609340,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时09分，木薯科学股票出现异动，股价急速上涨5.19%。截至发稿，该股报21.28美元/股，成交量10.8633万股，换手率0.23%，振幅4.40%。木薯科学股票所在的生物技术行业中，整体涨幅为1.29%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513220901861ecd4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513220901861ecd4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4588","SAVA","BK4585","BK4547"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cassavasciences.com","stockEarnings":[{"period":"1week","weight":-0.1242},{"period":"1month","weight":-0.4833},{"period":"3month","weight":-0.4868},{"period":"6month","weight":-0.618},{"period":"1year","weight":-0.5283},{"period":"ytd","weight":-0.5522}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cassava Sciences, Inc.是一家致力于开发新药的生物制药企业。公司主要候选药物称为羟考酮 (oxycodone) 缓释胶囊 。羟考酮是功效强大的止痛药，其独特的配方有助于减少非计划用量的潜在威胁。羟考酮和其他三种非滥用止疼药是按照与国王制药股份有限公司（King Pharmaceuticals, Inc.）的合作以及许可证协议（Pfizer Agreements）开发研制的。国王制药股份有限公司是辉瑞制药股份有限公司（Pfizer, Inc.）的子公司。公司于1998年5月在特拉华州注册成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.541667,"avgChangeRate":0.155421},{"month":2,"riseRate":0.416667,"avgChangeRate":0.028198},{"month":3,"riseRate":0.458333,"avgChangeRate":0.024377},{"month":4,"riseRate":0.583333,"avgChangeRate":0.060573},{"month":5,"riseRate":0.416667,"avgChangeRate":0.028089},{"month":6,"riseRate":0.458333,"avgChangeRate":-0.016342},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.04019},{"month":8,"riseRate":0.458333,"avgChangeRate":0.001895},{"month":9,"riseRate":0.583333,"avgChangeRate":0.111686},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.042533},{"month":11,"riseRate":0.625,"avgChangeRate":0.025539},{"month":12,"riseRate":0.375,"avgChangeRate":0.049835}],"exchange":"NASDAQ","name":"Cassava Sciences Inc","nameEN":"Cassava Sciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cassava Sciences Inc(SAVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cassava Sciences Inc(SAVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cassava Sciences Inc,SAVA,Cassava Sciences Inc股票,Cassava Sciences Inc股票老虎,Cassava Sciences Inc股票老虎国际,Cassava Sciences Inc行情,Cassava Sciences Inc股票行情,Cassava Sciences Inc股价,Cassava Sciences Inc股市,Cassava Sciences Inc股票价格,Cassava Sciences Inc股票交易,Cassava Sciences Inc股票购买,Cassava Sciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cassava Sciences Inc(SAVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cassava Sciences Inc(SAVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}